Washington State Life Science Investment Report – July

• Policy Blog
• 2025

Policy Blog – May 23, 2025 – House Bill Moves to Restore Immediate R&D Expensing — A Critical Step Forward

The reconciliation bill passed by the House this week includes a fix Life Science Washington and many others in our industry have been advocating for: restoring immediate expensing for R&D costs. Since the change to Section 174 of the tax code took effect in 2022, companies have been required to amortize R&D expenses over five […]

• Policy Blog
• 2025

Policy Blog – May 12, 2025 – Washington’s 2025 Legislative Session Ends with High Stakes and Hard-Fought Compromises

The 2025 Washington legislative session adjourned Sine Die on April 28 after 105 days of intense policymaking and budget negotiations. Despite expanded Democratic majorities, deep divisions over how to close a $16 billion deficit—driven by years of overspending and reliance on one-time federal funds—created frequent clashes within and across party lines, and with newly elected […]

• Policy Agenda
• 2025

2025 Legislative Outcomes

The 2025 legislative session ended with a $77.8 billion budget, deep political divisions, and critical tax decisions still pending final approval from Governor Ferguson. Life Science Washington helped block some of the most damaging proposals and continued advocating for policies that protect and grow Washington’s life sciences industry.  Below is a summary of key aspects […]

• Video Library
• 2025

Life Science Innovation in Washington State